Has Covid-19 put another nail in this FTSE 100 dividend stock’s coffin?

The FTSE 100 provides many opportunities for investors to go bargain hunting. But Royston Wild reckons this particular blue-chip is best avoided.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

We’re now a couple of months on since the coronavirus outbreak put the world on lockdown and shook financial markets. It’s too soon to predict with any accuracy the long-term changes global citizens will have to adopt. However, it’s clear that some FTSE 100 stocks stand to suffer considerably in a post-pandemic landscape.

One of these potential casualties is British American Tobacco (LSE: BATS). Why? Well, data suggests the number of smokers jacking in the habit has ballooned on the advice of health experts.

A joint study from YouGov and campaign group Action on Smoking and Health (ASH) suggests 300,000 smokers have tried to stub out for good during the crisis. A further 2.4m have cut down on the number of cigarettes they use too.

That comes amid claims smokers are more prone to initial infection and suffer difficulties during recovery. It follows comments from health secretary Matt Hancock, who recently claimed: “It is abundantly clear that smoking makes the impact of a coronavirus worse.”

Sales to slip

Global cigarette demand has been in a state of serious decline for years now. A ratcheting up of restrictions on the marketing, the sale, and the usage of tobacco products by governments the world over has smashed their grip on the general public. By the signs of it, the pandemic has stepped up the plight of Big Tobacco to a considerable degree. Not just in Britain, but across the world.

The likes of Footsie-quoted British American Tobacco aren’t quite in panic mode. Last week, BAT claimed it had made “a strong start to the year.” Volumes had grown amid a rise in both trade and consumer stocks, while a positive price mix has bolstered revenues too.

Don’t break out the bunting just yet. There’s a strong suggestion sales have surged in recent weeks due to panicked stockpiling by die-hard smokers. British American Tobacco said trade and consumer stocks are expected to reduce in the second quarter, crimping both industry volumes and sales growth in the period.

It’s clear the FTSE 100 colossus expects sales to tail off from the recent spike. That’s why it cut both its estimates for adjusted revenues and volumes (stick volumes are now expected to drop 5% in 2020).

Screen of price moves in the FTSE 100

A FTSE 100 stock I’d avoid

But is the Footsie firm worth the risk at current prices? British American Tobacco’s shares certainly look cheap on paper. At current prices, the tobacco titan changes hands on a price-to-earnings (P/E) ratio of 8.8 times for 2020.

It’s in the dividend stakes the company might attract the most attention though. Amid a sea of payout cuts from UK blue-chips, this particular mega-cap plans to keep on doling out dividends this year. And, based on current City predictions, this creates a bulky 7.4% yield.

I’m not tempted to buy by either of these readings though. British American Tobacco’s long-term outlook was looking pretty fragile even before the coronavirus crisis struck. Its earnings picture now looks flakier than ever. I’d much rather go bargain hunting elsewhere on the FTSE 100.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Yellow number one sitting on blue background
Investing For Beginners

My number 1 tip for Stocks and Shares ISA investors

This strategy has improved Edward Sheldon’s ISA returns dramatically and he thinks it could help other investors have more financial…

Read more »

White female supervisor working at an oil rig
Investing Articles

Down 20% in a year, is the BP share price simply too cheap to ignore?

After sliding for months, is the BP share price as low as it'll go? Even with the risk of more…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

4,123 shares of this UK dividend stock could get me £206 a month in passive income

Despite cutting its dividend significantly over the past five years, I think this FTSE 100 stock could be a good…

Read more »

Investing Articles

3 champion investments to beat the stock market in 2025

Looking for alpha? Dr James Fox details three investments that look destined to outperform the stock market in 2025 and…

Read more »

Investing Articles

2025 stock market recovery: a once-in-a-decade chance to get rich?

Zaven Boyrazian explains how he'd use the ongoing stock market recovery to his advantage, creating long-term wealth.

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

£20,000 in an ISA? Here’s how I’d aim to make £1,250 a month in passive income

Our writer thinks one rare FTSE 100 stock could help drive an ISA portfolio higher, resulting in a sizeable passive…

Read more »

Black father holding daughter in a field of cows
Investing Articles

£25k of savings? Consider aiming for a £1k+ monthly passive income via this strategy

With a long-term mindset, investors could target a four-figure monthly passive income by investing £25k in low-volatility blue-chip stocks.

Read more »

Investing Articles

The Rolls-Royce share price hit new highs in November. What next?

November has been another record-breaking month for the Rolls-Royce share price. And the outlook for 2025 still looks bright.

Read more »